BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2000
View Archived Issues
Novartis and Geneva Proteomics establish proteomics alliance
Read More
Idec Pharmaceuticals outlines significant Q3 events
Read More
IntraDose shows promise in treating liver metastases from colorectal cancer
Read More
Maxamine inhibits sarcomas in preclinical study
Read More
NIH awards Siga grant for vaccine research
Read More
AstraZeneca licenses antiarrhythmic drug candidate from Nortran
Read More
Phase III trial reveals potency of H. pylori treatment
Read More
IBS treatment launched in Japan by Hokuriku and Fujisawa
Read More
Meningococcal C meningitis vaccine approved for very young infants
Read More
Status of Dendreon's dendritic cell-based vaccines updated
Read More
Antidepressant-like activity observed in validated animal model for NK1 receptor antagonist
Read More
AF-2785 and related compounds as potential new male antifertility agents
Read More
Nonpeptide Y1 antagonist H-409/22 examined for in vivo effects on vascular responses
Read More
NCX-4016 superior to aspirin in reducing myocardial infarct size in animal model
Read More
New gelatinase inhibitors suppress endothelial cell proliferation and invasion
Read More
First topical treatment for AIDS-related Kaposi's sarcoma approved in E.U.
Read More
Cellular experiments suggest potential role for new dimer in prostate cancer therapy
Read More
Lorus reports promising phase I/II results with anticancer drug; supply alliance formed
Read More
NicOx designs improved antiinflammatory, analgesic and antithrombotic compounds
Read More
Preparation, activity and use of new acetylcholinesterase inhibitors reported by Eisai
Read More
AHP's new estrogen receptor modulators are useful in bone and cardiovascular diseases
Read More
Novel compounds identified at Merck as factor Xa inhibitors
Read More
New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo
Read More
Elan receives patent coverage for new integrin receptor antagonists
Read More
Potent new anti-HIV agents designed at Korean research institute
Read More
Ketolides from Abbott endowed with potent antibacterial activity
Read More